It was another supercharged year for the ultraluxury market, which saw at least seven deals cross the $100 million threshold.
Repsol in November signed a deal to sell upstream assets in Colombia to Latin American oil-and-gas explorer GeoPark for $530 million.
The Wall Street giant’s new group will capitalize on a private-credit surge and anticipated private-equity deal boom.
The deal would add to J & J’s portfolio lumateperone, an Intra-Cellular drug branded Caplyta, a pill that treats bipolar ...
Eli Lilly agreed to acquire Scorpion Therapeutics’ breast cancer treatment program for up to $2.5 billion in cash.
The boutique bank, long seen as a holdout, could sell a stake after recent interest from big investors.